Cognitive impairment in arterial hypertension
The article presents a current view on pathogenesis, diagnostic methods and treatment of cognitive disorders in patients with arterial hypertension. Choline alfoscerate drugs, precursors for choline drugs, are characterized. Prescription of the drugs for patients with hypertensive encephalopathy is...
| Published in: | Медицинский совет |
|---|---|
| Main Author: | M. V. Nesterova |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2015-12-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/268 |
Similar Items
Cognitive impairment in arterial hypertension
by: N. V. Pizova
Published: (2015-12-01)
by: N. V. Pizova
Published: (2015-12-01)
Применение холина альфосцерата в комплексном лечении больных, перенесших черепно-мозговую травму легкой, средней и тяжелой степени
Published: (2016-12-01)
Published: (2016-12-01)
Some aspects of treatment of neurodegenerative dementias
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01)
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01)
Therapeutic correction of cognitive disorders of various etiologies: a report from the 20th anniversary congress "Veinovskie Chtenia"
by: M. P. Verminsky
Published: (2024-04-01)
by: M. P. Verminsky
Published: (2024-04-01)
CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)
A neurotropic approach to the treatment of multi-infarct dementia using l-a-glycerylphosphorylcholine
by: Alberto Muratorio, et al.
Published: (2018-07-01)
by: Alberto Muratorio, et al.
Published: (2018-07-01)
Clinical experience in using cereton in ischemic stroke and dyscirculatory encephalopathy
by: L. P. Ponomareva, et al.
Published: (2010-06-01)
by: L. P. Ponomareva, et al.
Published: (2010-06-01)
Modern aspects of diagnosis and treatment of chronic cerebral ischemia. Application of naftidrofuryl
by: V. A. Parfyonov
Published: (2015-12-01)
by: V. A. Parfyonov
Published: (2015-12-01)
Choline supplements: An update
by: Urna Kansakar, et al.
Published: (2023-03-01)
by: Urna Kansakar, et al.
Published: (2023-03-01)
Management of patients with cognitive impairment
by: V. A. Parfenov
Published: (2023-02-01)
by: V. A. Parfenov
Published: (2023-02-01)
Treatment of cognitive impairment in the early postoperative period
by: L. V. Roshkovskaya, et al.
Published: (2018-07-01)
by: L. V. Roshkovskaya, et al.
Published: (2018-07-01)
Cognitive disorders and dysphagia in the elderly: A review
by: Valentina S. Ostapenko, et al.
Published: (2024-05-01)
by: Valentina S. Ostapenko, et al.
Published: (2024-05-01)
The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment
by: D. V. Zakharov, et al.
Published: (2021-12-01)
by: D. V. Zakharov, et al.
Published: (2021-12-01)
Experience in using ceretone (choline alfoscerate) in brain concussion
by: N. G. Voropay, et al.
Published: (2010-12-01)
by: N. G. Voropay, et al.
Published: (2010-12-01)
Choline alfoscerate in the correction of cognitive impairment
by: O. A. Shavlovskaya, et al.
Published: (2023-12-01)
by: O. A. Shavlovskaya, et al.
Published: (2023-12-01)
МЕХАНИЗМ РАЗВИТИЯ КОГНИТИВНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ
by: Л. В. Никонова, et al.
Published: (2024-09-01)
by: Л. В. Никонова, et al.
Published: (2024-09-01)
Algorithm for selecting therapy for vascular cognitive impairment
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01)
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01)
Prediction for vascular mild cognitive impairment using the p300 event-related potentials technique
by: Yu. V. Sturova, et al.
Published: (2014-10-01)
by: Yu. V. Sturova, et al.
Published: (2014-10-01)
Pantogam activ (D-, L-hopantenic acid) in the treatment of cognitive and anxiety disorders in patients with arterial hypertension
by: A. B. Smulevich, et al.
Published: (2018-07-01)
by: A. B. Smulevich, et al.
Published: (2018-07-01)
Clinical and neurophysiological analysis of correction of mild cognitive impairment in patients with dyscirculatory encephalopathy
by: E. N. Madzhidova, et al.
Published: (2013-12-01)
by: E. N. Madzhidova, et al.
Published: (2013-12-01)
The clinical, diagnostic and therapeutic aspects of amnestic mild cognitive impairment
by: N. N. Koberskaya
Published: (2015-12-01)
by: N. N. Koberskaya
Published: (2015-12-01)
EEG analysis of trial subjects with discirculatory encephalopathy by multidimensional scaling method of cognitive tests and leads
by: Anna I. Novikova, et al.
Published: (2017-10-01)
by: Anna I. Novikova, et al.
Published: (2017-10-01)
Clinical manifestations at the initial stage of child neuropathy formation: an analytical review
by: G. G. Butorin, et al.
Published: (2018-07-01)
by: G. G. Butorin, et al.
Published: (2018-07-01)
Diagnosis and treatment of post-stroke cognitive impairment
by: I. S. Preobrazhenskaya
Published: (2014-12-01)
by: I. S. Preobrazhenskaya
Published: (2014-12-01)
Cognitive impairment in patients with bone marrow transplantation (review)
by: S. Yu. Fedorova, et al.
Published: (2018-07-01)
by: S. Yu. Fedorova, et al.
Published: (2018-07-01)
ФИТОТЕРАПИЯ В РЕАБИЛИТАЦИИ ЛЕГКИХ И УМЕРЕННЫХ КОГНИТИВНЫХ РАССТРОЙСТВ
by: С. С. Василевский, et al.
Published: (2023-06-01)
by: С. С. Василевский, et al.
Published: (2023-06-01)
FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. S. Akimova, et al.
Published: (2015-09-01)
by: N. S. Akimova, et al.
Published: (2015-09-01)
Cognitive impairment in arterial hypertension
by: N. V. Vakhnina
Published: (2015-12-01)
by: N. V. Vakhnina
Published: (2015-12-01)
Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea
by: Yeon Hee Kim, et al.
Published: (2024-10-01)
by: Yeon Hee Kim, et al.
Published: (2024-10-01)
CONTEMPORARY APPROACH TO THE CORRECTION OF COGNITIVE DISORDERS IN PATIENTS WITH VASCULAR COMORBIDITY
by: S. A. Rumianceva, et al.
Published: (2015-09-01)
by: S. A. Rumianceva, et al.
Published: (2015-09-01)
Faktory sosudistogo riska, kognitivnyerasstroystva i izmeneniya kartiny MRT golovnogomozga u bol'nykh sakharnym diabetom 2 tipa
by: Lyudmila Alexandrovna Chugunova, et al.
Published: (2006-12-01)
by: Lyudmila Alexandrovna Chugunova, et al.
Published: (2006-12-01)
Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers
by: Min MH, et al.
Published: (2019-04-01)
by: Min MH, et al.
Published: (2019-04-01)
CHOLINE PREPARATIONS IN THE TREATMENT OF ASTHENIC STATES: MODERNITY AND PERSPECTIVES (A LITERATURE REVIEW WITH A CLINICAL CASE PRESENTATION)
by: Kamila Sh. Magomedova, et al.
Published: (2023-04-01)
by: Kamila Sh. Magomedova, et al.
Published: (2023-04-01)
Cognitive functionбpsychoemotional disorders and quality of life in patients with acute ischemic stroke
by: O. E. Malneva, et al.
Published: (2018-07-01)
by: O. E. Malneva, et al.
Published: (2018-07-01)
Cognitive profile of patients with depressive disorders and its significance for antidepressant therapy and social functioning
by: K. E. Emelin, et al.
Published: (2018-07-01)
by: K. E. Emelin, et al.
Published: (2018-07-01)
Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance
by: Khanh Linh Duong, et al.
Published: (2024-11-01)
by: Khanh Linh Duong, et al.
Published: (2024-11-01)
Post-traumatic cognitive disorders: the cholinergic therapy options
by: O. S. Levin, et al.
Published: (2024-06-01)
by: O. S. Levin, et al.
Published: (2024-06-01)
Application of neuroprotectors in severe brain injuries
by: O. Ye. Vaizova, et al.
Published: (2011-10-01)
by: O. Ye. Vaizova, et al.
Published: (2011-10-01)
Perspectives for diagnostic and treatment in alcoholic encephalopathy at early disease stage
by: E. R. Barantsevich, et al.
Published: (2015-12-01)
by: E. R. Barantsevich, et al.
Published: (2015-12-01)
Роль метаболических нарушений в формировании когнитивной дисфункции при сахарном диабете 2 типа = Role of metabolic disorders in the formation of cognitive dysfunction in type 2 diabetes mellitus
by: O. L. Tovazhnyanska, et al.
Published: (2016-08-01)
by: O. L. Tovazhnyanska, et al.
Published: (2016-08-01)
Similar Items
-
Cognitive impairment in arterial hypertension
by: N. V. Pizova
Published: (2015-12-01) -
Применение холина альфосцерата в комплексном лечении больных, перенесших черепно-мозговую травму легкой, средней и тяжелой степени
Published: (2016-12-01) -
Some aspects of treatment of neurodegenerative dementias
by: I. S. Preobrazhenskaya, et al.
Published: (2014-12-01) -
Therapeutic correction of cognitive disorders of various etiologies: a report from the 20th anniversary congress "Veinovskie Chtenia"
by: M. P. Verminsky
Published: (2024-04-01) -
CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)
